Manufacturing

This article explores the concerns with cleaning pharmaceutical products utilizing LNP delivery vehicles and provides a general cleaning recommendation based on laboratory and field testing.

The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.

Precompetitive consortiums seek solutions to industry-wide challenges.

ROSS reconditioned DPM-40 Double Planetary Mixers offer comparable production to new mixers at a lower cost.

Standard BioTools’ Hyperion+ Imaging System can process more samples and has lower limits of detection than its predecessor.

Colorcon’s OptiClenz delivers cGMP-validated high-performance coating equipment cleaning.

AMETEK Haydon Kerk Pittman’s 57mm size motor in its IDEA Motor series is designed for real-time, embedded motion control.

AI could provide solutions to critical manufacturing inefficiencies.

Biograd Diagnostics has chosen the Matrix Gemini system by Autoscribe Informatics as its laboratory information management system for managing COVID-19 test samples.

AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.

Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.

The agency is asking drug manufacturers to ensure a strong supply chain by developing risk management plans.

Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.

In this episode of the Drug Solutions Podcast, Chris Spivey, editorial director, interviews Michael Kopcha, Sau Lee, and Cindy Buhse of FDA about not being afraid to try new approaches and how they invite fresh ideas and abundant communication.

Innovations address sustainability, serialization, and supply-chain issues.

Flexible and efficient methods are needed for biopharmaceutical manufacturing.

The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.

By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.

The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.

Lighthouse manufacturing techniques utilize technology and automation to streamline production.

The need for sustainability and early considerations of a lyophilization strategy grow more pertinent on the back of growing biologics volume.

CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.

The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.

Several steps need be taken to achieve lights-out, fully automated operations.

Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.